Yashar Zeighami

Assistant Professor

McGill University
Country flagCanada
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (16)

Genetic studies have advanced our understanding of Parkinson's disease (PD) pathogenesis, establishing a role for autophagy and lysosomal dysfunction. However, how genetic risk translates into neuronal vulnerability remains mostly unknown. Using recent genome-wide association studies and neuroimaging data from UK Biobank, we show that higher polygenic risk score of PD correlates with greater cortical surface area, white matter fractional anisotropy and subcortical volumes. Mendelian randomization supports a causal relation from increased brain size to PD, and cortical regions showing the greatest polygenic expansion in surface area show the greatest atrophy in PD. Lifespan gene expression and pathway-specific analyses identify autophagy-lysosomal and neurodevelopmental pathways as separate mechanisms of vulnerability. We show that a portion of PD susceptibility originates from neurodevelopmental processes that regulate neuronal proliferation. Genetically-determined increases in brain size confer vulnerability to PD in later life, supporting the existence of shared neurobiological pathways between brain development and neurodegeneration.

Year:

2025

Frontotemporal Dementia (FTD) is a neurodegenerative disorder characterized by extensive atrophy in the frontal and temporal lobes of the brain as well as high cerebrovascular burden. While anatomical Magnetic Resonance Imaging (MRI) is well established for quantifying brain atrophy in FTD, the variability in (pre-)processing methods limits the generalizability and comparability of findings. This study systematically compared the robustness and sensitivity of multiple widely used neuroimaging metrics, namely Deformation-Based Morphometry (DBM), Voxel-Based Morphometry (VBM), Cortical Thickness (CT), and segmentation-based grey matter Volumes, in detecting atrophy across FTD subtypes. We processed 732 T1-weighted MRI scans from 156 participants with FTD and 139 healthy controls from the Frontotemporal Lobar Degeneration Neuroimaging Initiative using our in-house pipeline PELICAN (Dadar et al., 2025) for volumetric measures and FreeSurfer version 7 (Fischl, 2012) for CT and grey matter segmentations. Visual quality control using consistent quality control images at each step of the pipelines revealed significantly higher failure rates for CT (38.52%) and FreeSurfer segmentations (23.63%) relative to PELICAN’s volumetric measures (2.04% DBM, 3.05% VBM). Failure rates differed between FTD subtypes and were related to pathological burden. Particularly for FreeSurfer, errors occurred predominantly in regions with high prevalence of atrophy and White Matter Hyperintensities. In PELICAN, the addition of a FTD-specific template as an intermediate step during nonlinear registration decreased the failure rates in this step in the FTD population. We then applied linear regression models to assess each metric’s sensitivity in detecting cross-sectional differences between FTD groups controls as well as linear mixed-effects models to determine which method is most sensitive to longitudinal anatomical changes. While CT yielded effect sizes comparable to VBM and DBM when analyzing the same subset of successfully processed scans, VBM and DBM demonstrated enhanced power to detect effects due to lower failure rates and higher participant retention in the full sample. Overall, we demonstrate that image processing methodology and pipeline selection profoundly influences effect sizes and statistical power to detect meaningful between-group differences or longitudinal changes. Volumetric measures (DBM and VBM) yielded sufficiently robust pipeline outcomes to maintain adequate statistical power for capturing atrophy patterns after quality control procedures.

Year:

2025

Post-mortem magnetic resonance imaging (MRI) offers high resolution and histological correlation, so protocols have been developed by brain banks using hemispheres fixed by immersion in Neutral-buffered formalin (NBF), but they provide limited tissue samples. Conversely, anatomy laboratories could supply complete brains perfused either with a salt-saturated (SSS) or an alcohol-formaldehyde (AFS) solution. These fixation methods alter the brain’s molecular properties, potentially affecting MRI quality and structural characteristics. T1- and T2-weighted (T1w, T2w) contrasts change with NBF fixation, but the effects of SSS or AFS remain unknown. We compared T1w and T2w intensities of different regions of interest (ROIs), including subcortical white matter (WM), cortical and deep gray matter (GM), in brains fixed with NBF, SSS and AFS. We scanned 20 ex situ hemispheres (NBF-immersed=7; SSS-perfused=7; AFS-perfused=6) in a 3T MRI scanner using T1w (0.7mm 3 ) and T2w (0.64mm 3 ) sequences overnight. Mean intensities of 29 ROIs in T1w and T2w MRIs and GM-WM ratios were calculated and compared in brains fixed with the three solutions. We found that T1w images were more affected by the fixation process, inverting the contrast of in vivo T1w and reducing the GM-WM contrast in AFS-fixed brains. T2w images resembled in vivo scans and maintained a sharp contrast in brains fixed with the three solutions, although the GM-WM intensity ratios were lowered in SSS-fixed brains. In conclusion, brains fixed with SSS and AFS from anatomy laboratories could be used for MRI studies, especially with the T2w sequence that seems more appropriate for structural analyses in different ROIs.

Year:

2025

The human brain and peripheral systems undergo coordinated changes throughout the lifespan, yet studies of aging have traditionally examined these systems as separate entities. Here we ask how brain health relates to peripheral biomarkers of bodily health including body mass index, blood pressure, and blood biochemistry results. We use partial least squares analysis to identify generalizable patterns of covariance between multi-modal neuroimaging data (structural, functional, diffusion, and arterial spin labeling MRI), demographic, and peripheral physiological markers in two large-scale deeply phenotyped datasets: the Human Connectome Project-Aging and UK Biobank. This data-driven pattern learning approach identifies two principal axes of brain-body associations in both biological sex groups. The first axis is driven by the dominant contribution of age. Across multiple brain measures, aging is associated with loss of brain structural integrity and cerebral vascular dysfunction. The second axis is driven by metabolic features, characterized by low high-density lipoprotein cholesterol, elevated body mass index, blood pressure, glycosylated hemoglobin, insulin, glucose, and alanine aminotransferase, and reduced cerebral blood perfusion. Finally, we show that deviations from a healthy metabolic profile are linked to cognitive deficits, particularly in females. Our study contributes to development of comprehensive translatable biomarkers for brain health assessment, and highlights the importance of metabolic health as a determinant of brain health.

Year:

2025

Due to their high inter-tissue contrast, Magnetic resonance images (MRIs) can reflect neuroanatomical changes related to healthy aging and pathological processes. However, standard brain MRI acquisition resolutions hinder the ability to measure the more subtle changes that occur in early disease stages. Increasing the resolution during acquisition poses multiple challenges, including increased noise, higher acquisition times and cost, and discomfort of the scanned individual. In this work, we propose a robust, generalizable single-image super-resolution network for brain MRIs named Resolution Augmentation with Variational auto-Encoder Networks (RAVEN) with generative adversarial networks (GANs). We show RAVEN is capable of upsampling in-vivo and ex-vivo MRIs of diverse modalities (e.g. T1-weighted, T2-weighted, and T2*) and varying field strengths (3T to 7T) to target voxel sizes as small as 0.5mm isotropic using arbitrary upsampling factors. RAVEN achieved state-of-the-art performance against deep learning and non-deep learning methods, best preserving true anatomical information. We have also made RAVEN open access, with the source code as well as training and evaluation scripts available and ready to use at: https://github.com/waadgo/raven .

Year:

2025

Structural magnetic resonance imaging (MRI) allows for accurate non-invasive assessment of the brain’s structure and its longitudinal changes. Availability of large scale longitudinal MRI datasets enables us to probe brain changes in health and disease, and derive longitudinal trajectories of brain morphometry based measures to estimate brain atrophy and other disease-related abnormalities. In contrast to their cross-sectional counterparts, image processing pipelines that have been designed for longitudinal data can reduce noise in the derived measurements by disentangling the within and between subject variabilities, improving the sensitivity of the downstream models in detecting more subtle longitudinal changes. Here we present PELICAN, our open source multi-contrast longitudinal image processing pipeline, that has been designed and extensively validated for use in longitudinal settings and populations with neurodegenerative disorders. PELICAN can use population specific average templates as intermediate targets to derive accurate nonlinear registrations for cases with substantial levels of atrophy, which commonly used pipelines struggle to process. We evaluated PELICAN’s performance across over 34,000 MRIs from multiple aging and neurodegenerative disorder cohorts, and compared its reliability and failure rates against FreeSurfer as a widely used image processing tool, showing superior performance of PELICAN compared to FreeSurfer, both in terms of failure rate and reliability. Our results demonstrate that PELICAN can be used to accurately process MRIs of individuals with neurodegenerative disease who present with greater levels of atrophy and white matter lesion burden.

Year:

2025

Cell-cell communication is essential for proper brain functioning and health. Here, we characterize whole-brain patterns of cellular interactions that spatially align with tissue damage across 13 neurodegenerative conditions, including early- and late-onset Alzheimer’s disease (EOAD, LOAD), presenilin-1 mutations (PS1), frontotemporal lobar degeneration, Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and amyotrophic lateral sclerosis (ALS). By integrating spatial gene expression with structural MRI data, we created over 1,000 whole-brain maps of ligand-receptor interactions. Multivariate analysis revealed three principal axes of cell-cell communication underlying brain tissue vulnerability. The first axis involved neuron-astrocyte-microglia interactions, explaining atrophy patterns shared by frontotemporal lobar degeneration and Alzheimer’s disease subtypes. Moreover, the first axis was enriched with genes involved in regulation or spreading of Aβ/tau and/or Alzheimer’s disease risk. Two complementary axes involving neurons, endothelial cells, and astrocytes explained patterns specific to PS1 and PD. Notably, we confirmed that cell-cell interactions identified for LOAD were also associated with frontal cortex atrophy in 375 participants from an independent database. These findings reveal both distinctive and shared molecular signaling pathways underlying tissue vulnerability across neurodegenerative disorders, clarifying disease mechanisms and highlighting potential cellular targets for therapeutic interventions.

Year:

2025

INTRODUCTION Education can protect against cognitive decline and dementia through cognitive reserve and reduced vascular risk. This study examined whether vascular risk mediates the relationship between education and white matter hyperintensity (WMH) burden. METHODS Data from 1089 older adults from the National Alzheimer’s Coordinating Center were analyzed. A composite vascular score was created using diabetes, hypertension, hypercholesterolemia, smoking, alcohol abuse, body mass index, and blood pressure. Linear regressions and mediation analyses examined associations and indirect effects between education, vascular risk, and WMH, adjusting for age, sex, and diagnosis. RESULTS Higher education was associated with lower vascular risk ( p < .001) and WMH burden ( p = .01). Mediation analysis showed an indirect effect of education on WMH via vascular risk (a*b = −0.02, p = .004), accounting for 23% of the total effect. DISCUSSION Education influences cerebrovascular health via reducing vascular risk. Addressing vascular health may reduce WMH burden.

Year:

2025

Introduction While the link between presence of amyloid and tau pathologies, neurodegeneration, and cognitive decline in aging individuals is established, it is less clear whether there are sex differences in vulnerability to these pathologies. Methods 1,464 participants (7,168 longitudinal assessments, 4.77±3.78 years of follow-up) were included from the National Alzheimer’s Coordinating Center (NACC) database. Longitudinal mixed effects and mediation models examined the sex differences across cognitive decline trajectories of amyloid (A), tau (T), and neurodegeneration (N) groups. Results A + T - males showed faster cognitive decline compared to A + T - females (p<0.005), whereas A + T + females showed steeper cognitive decline compared to A + T + males (p<0.0001). Sex also marginally moderated the mediating effect of tau on the relationship between amyloid and cognitive decline (p=0.046). Discussion Sex differences in vulnerability to tau pathology in presence of amyloid can shape cognitive decline trajectories. Highlights A + T - males showed faster cognitive decline compared to A + T - females A + T + females showed faster cognitive decline compared to A + T + males Tau status significantly mediated the relationship between amyloid status and cognitive decline Sex marginally moderated the mediating relationship between amyloid, tau, and cognitive decline The findings point to sex differences in the impact of tau pathology on cognition

Year:

2025

Blood perfusion delivers oxygen and nutrients to all cells, making it a fundamental feature of brain organization. How cerebral blood perfusion maps onto micro-, meso- and macro-scale brain structure and function is therefore a key question in neuroscience. Here we analyze pseudo-continuous arterial spin labeling (ASL) data from 1,305 healthy individuals in the HCP Lifespan studies (5-100 years) to reconstruct a high-resolution normative cerebral blood perfusion map. At the cellular and molecular level, cerebral blood perfusion co-localizes with granular layer IV, biological pathways for maintenance of cellular relaxation potential and mitochondrial organization, and with neurotransmitter and neuropeptide receptors involved in vasomodulation. At the regional level, blood perfusion aligns with cortical arealization and is greatest in regions with high metabolic demand and resting-state functional hubs. Looking across individuals, blood perfusion is dynamic throughout the lifespan, follows micro-architectural changes in development, and maps onto individual differences in physiological changes in aging. In addition, we find that cortical atrophy in multiple neurodegenerative diseases (late-onset Alzheimer's disease, TDP-43C, and dementia with Lewy bodies) is most pronounced in regions with lower perfusion, highlighting the utility of perfusion topography as an indicator of transdiagnostic vulnerability. Finally, we show that ASL-derived perfusion can be used to delineate arterial territories in a data-driven manner, providing insights into how the vascular system is linked to human brain function. Collectively, this work highlights how cerebral blood perfusion is central to, and interlinked with, multiple structural and functional systems in the brain.

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (17)

Yasser Iturria Medina

Associate Professor

Montreal Neurological Institute and Hospital

CANADA
View details

Ziv Gan-Or

Montreal Neurological Institute and Hospital

CANADA
View details

Danilo Bzdok

-

CANADA
View details

D. Louis Collins

Professor

McGill University

CANADA
View details

Corina Nagy

Associate Professor

McGill University

CANADA
View details

Justine Hansen

McGill University

CANADA
View details

Mahsa Dadar

Assistant Professor

McGill University

CANADA
View details

Cassandra Morrison

Carleton University

CANADA
View details

Andre Tchernof

Professeur

Institut universitaire de cardiologie et de pneumologie de Québec

CANADA
View details

Claudine Gauthier

Professor

Concordia University

CANADA
View details

Neda Jahanshad

University of Southern California

UNITED STATES
View details

Bratislav Misic

Associate Professor

McGill University

CANADA
View details

Filip Morys

Research Associate

McGill University

CANADA
View details

Denis Boire

Adjunct professor

Université de Montréal

CANADA
View details

Mallar Chakravarty

Professor

McGill University

CANADA
View details

Jean-Baptiste Poline

McGill University

CANADA
View details

Alain Dagher

Professor

McGill University

CANADA
View details